EarlySense to integrate UChicago physician's predictive cardiac arrest tool into patient monitoring products

Jessica Kim Cohen - Print  | 

EarlySense, a continuous patient monitoring solutions vendor, signed a deal for exclusive global rights to eCART, a clinical predictive analytics tool developed by Dana Edelson, MD, executive medical director of rescue care at the University of Chicago.

EarlySense will integrate the eCART 'Lite' early warning score tool, which analyzes patients' heart and respiratory rates to predict their risk of cardiac arrest, into its monitoring products. EarlySense's products passively collect vital signs — including heart and respiratory data — while patients lie in bed or sit in a chair, and use artificial intelligence and analytics for early detection of patient deterioration.

"Combining Dr. Edelson's approach with real-time data enhances true deterioration detection," Avner Halperin, co-founder and CEO of EarlySense, said in a May 30 statement. "We are pleased to collaborate with her to bring state-of-the-art data analytics to hospitals, post-acute care facilities and homes."

More articles on data analytics & precision medicine:
Breach at DTC genetic testing company MyHeritage hits 92M users
Dana-Farber Cancer Institute, Philips partner to provide cancer decision support to physicians
23andMe sues Ancestry.com: 5 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.